Ocugen Inc
NASDAQ:OCGN

Watchlist Manager
Ocugen Inc Logo
Ocugen Inc
NASDAQ:OCGN
Watchlist
Price: 0.9862 USD -8.69% Market Closed
Market Cap: 283.9m USD
Have any thoughts about
Ocugen Inc?
Write Note

EV/OCF
Enterprise Value to OCF

-5.9
Current
-6.9
Median
6
Industry
Higher than median
Lower than industry value

Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.

EV/OCF
-5.9
=
Enterprise Value
269.7m USD
/
Operating Cash Flow
-45.5m USD
All Countries
Close
Market Cap EV/OCF
US
Ocugen Inc
NASDAQ:OCGN
283.9m USD -5.9
FR
Pharnext SCA
OTC:PNEXF
6T USD -232 635.4
US
Abbvie Inc
NYSE:ABBV
352.5B USD 24.5
US
Amgen Inc
NASDAQ:AMGN
174.8B USD 30.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
133.2B USD -134.3
US
Gilead Sciences Inc
NASDAQ:GILD
120.3B USD 11.5
US
Epizyme Inc
F:EPE
94.1B EUR -484
AU
CSL Ltd
ASX:CSL
137.9B AUD 36.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
91.2B USD 19.8
US
Seagen Inc
F:SGT
39.3B EUR -75.8
NL
argenx SE
XBRU:ARGX
33.2B EUR -125.1
 
US
Ocugen Inc
NASDAQ:OCGN
Average EV/OCF: 24.6
Negative Multiple: -5.9
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -232 635.4
US
Abbvie Inc
NYSE:ABBV
24.5
US
Amgen Inc
NASDAQ:AMGN
30.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -134.3
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -484
AU
CSL Ltd
ASX:CSL
36.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.8
US
S
Seagen Inc
F:SGT
Negative Multiple: -75.8
NL
argenx SE
XBRU:ARGX
Negative Multiple: -125.1

EV/OCF Forward Multiples

Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A

See Also

Discover More